Second Chance for Moms Act

Bill: 118-hr-7823
Sponsor: full_name: Rep. Miller, Mary E. [R-IL-15]
Introduced: 2024-03-26
Policy area: Health
Latest action: action_date: 2024-03-29
text: Referred to the Subcommittee on Health.

Summaries:

tv_txt: I 118th CONGRESS 2d Session H. R. 7823 IN THE HOUSE OF REPRESENTATIVES March 26, 2024 Mrs. Miller of Illinois (for herself, Mr. Babin , Ms. Hageman , Mr. Rosendale , Mrs. Harshbarger , Mr. Banks , and Mr. Webster of Florida ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

1. Short title This Act may be cited as the Second Chance for Moms Act . 2. Mifepristone warning label and hotline (a) Warning label (1) In general Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (hh) If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance of fetal survival. The American Society for Reproductive Medicine has determined that natural progesterone is safe in the first trimester of pregnancy. For more information, call [___]. (with the blank filled in to refer to the appropriate number for the hotline under section 1009 of the Public Health Service Act). . (2) Effective date Section 502(hh) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1)) applies beginning on the date that is 6 months after the date of enactment of this Act. (b) Hotline Title X of the Public Health Service Act ( 42 U.S.C. 300 et seq. ) is amended by adding at the end the following: 1009. Hotline for reversal of effects of mifepristone The Secretary shall establish or maintain, directly or by grant or contract, a toll-free hotline to provide support for 24 hours a day, 7 days a week, for women seeking to reverse the effects of the drug mifepristone. .